View All Pages

Breast Cancer - Inflammatory - Introduction

Approved by the Cancer.Net Editorial Board, 06/2022

ON THIS PAGE: You will find some basic information about this disease and the parts of the body it may affect. This is the first page of Cancer.Net’s Guide to Inflammatory Breast Cancer. Use the menu to see other pages. Think of that menu as a roadmap for this entire guide.

About the breast

The breast is made up of different tissue, ranging from very fatty tissue to very dense tissue. Within this tissue is a network of lobes. The lobes are made up of tiny, tube-like structures called lobules that contain milk glands. Tiny ducts connect the glands, lobules, and lobes. These ducts carry the milk from the lobes to the nipple, located in the middle of the areola. The areola is the darker area that surrounds the nipple. Blood and lymph vessels also run throughout the breast. Blood nourishes the cells, and the lymph system drains bodily waste products. The lymph vessels connect to lymph nodes, the small, bean-shaped organs that help fight infection.

About inflammatory breast cancer

Cancer begins when healthy cells in the breast change and grow out of control, forming a mass or sheet of cells called a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread. Breast cancer spreads when the cancer grows into other parts of the body or when breast cancer cells move to other parts of the body through the blood vessels and/or lymph vessels. This is called metastasis.

Inflammatory breast cancer is a less common form of breast cancer. The cancer gets its name because it causes symptoms that are similar to a breast infection. These symptoms include redness, tenderness, swelling, and pain in the breast. However, unlike an infection, inflammatory breast cancer does not improve with antibiotic treatment.

In inflammatory breast cancer, the cancer cells enter and block the lymph vessels within the breast. This blockage can cause the breast and its skin to swell up because the lymph fluid cannot leave. It can also cause the breast to look red and inflamed. Inflammatory breast cancer often grows quickly and has a higher risk of spreading than other types of breast cancer. This means that treatment often needs to be started quickly and requires a team approach by doctors. Treatment usually includes a combination of chemotherapy, surgery, radiation therapy, and possibly hormonal, or endocrine, therapy. These treatments are explained in the Types of Treatment section.

Breast cancer subtypes

Breast cancer is not a single disease, even among the same type of breast cancer. When you are diagnosed with breast cancer, your doctor will recommend doing lab tests on the cancerous tissue. These tests help your doctor find out more about cancer and choose the most effective treatment.

Testing can determine if the cancer is hormone receptor positive or negative, human epidermal growth factor receptor 2 (HER2) positive or negative, or triple negative. These terms are explained below:

  • Hormone receptor positive or negative. Breast cancers expressing estrogen receptors (ER) and progesterone receptors (PR) are called “hormone receptor positive.” These cancers may depend on the hormones estrogen and/or progesterone to grow. A breast cancer that does not have estrogen and progesterone receptors is called “hormone receptor negative.”

  • HER2 positive or negative. About 10% to 20% of breast cancers depend on the gene called human epidermal growth factor receptor 2 (HER2) to grow. These cancers are called “HER2 positive” and have too many HER2 receptors and/or extra copies of the HER2 gene. The HER2 gene makes a protein that is found on the cancer cell and is important for tumor cell growth. A breast cancer that does not have excessive numbers of HER2 receptors or copies of the HER2 gene is called “HER2 negative.”

  • Triple negative. If a breast tumor does not express ER, PR, and/or HER2, it is called “triple negative.” This type of breast cancer may grow more quickly than hormone receptor-positive disease, and chemotherapy may work better as a treatment. About 20% of inflammatory breast cancers are triple negative.

Looking for More of an Introduction?

If you would like more of an introduction to breast cancer, explore these related items. Please note that these links will take you to other sections on Cancer.Net:

  • ASCO Answers Fact Sheet: Read a 1-page fact sheet that offers an introduction to breast cancer. This free fact sheet is available as a PDF, so it is easy to print.

  • ASCO Answers Guide: Get this free 52-page booklet that helps you better understand breast cancer and treatment options. The booklet is available as a PDF, so it is easy to print.

The next section in this guide is Statistics. It helps explain the number of people who are diagnosed with inflammatory breast cancer and general survival rates. Use the menu to choose a different section to read in this guide.

Breast Cancer - Inflammatory - Statistics

Approved by the Cancer.Net Editorial Board, 02/2023

ON THIS PAGE: You will find information about the estimated number of people who will be diagnosed with inflammatory breast cancer each year. You will also read general information on surviving the disease. Remember, survival rates depend on many factors, and no 2 people with cancer are the same. Use the menu to see other pages.

Every person is different, with different factors influencing their risk of being diagnosed with this cancer and the chance of recovery after a diagnosis. It is important to talk with your doctor about any questions you have around the general statistics provided below and what they may mean for you individually. The original sources for these statistics are provided at the bottom of this page.

How many people are diagnosed with inflammatory breast cancer?

Inflammatory breast cancer makes up an estimated 1% to 5% of all breast cancers in the United States. The disease typically occurs in women younger than 40. Black women seem to have a higher risk of inflammatory breast cancer than White women. Inflammatory breast cancer can also occur in men. Men are typically older when they are diagnosed with inflammatory breast cancer when compared with women.

Because inflammatory breast cancer can grow and spread quickly, this cancer often spreads to the lymph nodes around the breast. This means it is usually at a locally advanced stage when it is first diagnosed because the breast cancer cells have grown into the skin. For about 1 out of 3 people with inflammatory breast cancer, the cancer has already spread to distant parts of the body when first diagnosed.

What is the survival rate for inflammatory breast cancer?

There are different types of statistics that can help doctors evaluate a person’s chance of recovery from inflammatory breast cancer. These are called survival statistics. A specific type of survival statistic is called the relative survival rate. It is often used to predict how having cancer may affect life expectancy. Relative survival rate looks at how likely people with inflammatory breast cancer are to survive for a certain amount of time after their initial diagnosis or start of treatment compared to the expected survival of similar people without this cancer.

Example: Here is an example to help explain what a relative survival rate means. Please note this is only an example and not specific to this type of cancer. Let’s assume that the 5-year relative survival rate for a specific type of cancer is 90%. “Percent” means how many out of 100. Imagine there are 1,000 people without cancer, and based on their age and other characteristics, you expect 900 of the 1,000 to be alive in 5 years. Also imagine there are another 1,000 people similar in age and other characteristics as the first 1,000, but they all have the specific type of cancer that has a 5-year survival rate of 90%. This means it is expected that 810 of the people with the specific cancer (90% of 900) will be alive in 5 years.

It is important to remember that statistics on the survival rates for people with inflammatory breast cancer are only an estimate. They cannot tell an individual person if cancer will or will not shorten their life. Instead, these statistics describe trends in groups of people previously diagnosed with the same disease, including specific stages of the disease.

The 5-year relative survival rate for inflammatory breast cancer in the U.S. is 40%.

The survival rates for inflammatory breast cancer vary based on several factors. These include the stage of cancer, a person’s age and general health, and how well the treatment plan works. Another factor that can affect outcomes is whether the cancer has certain features.

If the cancer has spread to the regional lymph nodes, the 5-year relative survival rate is 54%. If the cancer has spread to a distant part of the body, the 5-year relative survival rate is 19%.

Experts measure relative survival rate statistics for inflammatory breast cancer every 5 years. This means the estimate may not reflect the results of advancements in how inflammatory breast cancer is diagnosed or treated from the last 5 years. Talk with your doctor if you have any questions about this information. Learn more about understanding statistics.

Statistics adapted from the American Cancer Society and National Cancer Institute websites. (All sources accessed February 2023.)

The next section in this guide is Medical Illustrations. It offers a drawing of body parts often affected by inflammatory breast cancer. Use the menu to choose a different section to read in this guide.

Breast Cancer - Inflammatory - Medical Illustrations

Approved by the Cancer.Net Editorial Board, 06/2023

ON THIS PAGE: You will find a drawing of the main body parts affected by inflammatory breast cancer. Use the menu to see other pages.

Illustration of breast tissue shown on a Black woman

The image is a drawing of a person’s breasts. The breast is made up of different types of tissue, which sit on top of the pectoralis major muscle over the ribcage. Within the fatty tissue of the breast is a network of lobes, made up of tiny, tube-like structures called lobules that contain milk glands. Lactiferous ducts connects the lobes, glands, and lobules to carry milk to the nipple, located in the middle of the areola, the darker area that surrounds the nipple. Lymph vessels also run through the breast, and connect to axillary lymph nodes, tiny, bean-shaped organs that are found in groupings in various parts of the body, including the armpits. Copyright 2003 American Society of Clinical Oncology. Robert Morreale/Visual Explanations, LLC.

The next section in this guide is Risk Factors. It explains the factors that may increase the chance of developing inflammatory breast cancer. Use the menu to choose a different section to read in this guide.

Breast Cancer - Inflammatory - Risk Factors

Approved by the Cancer.Net Editorial Board, 06/2022

ON THIS PAGE: You will find out more about the factors that increase the chance of developing inflammatory breast cancer. Use the menu to see other pages.

A risk factor is anything that increases a person’s chance of developing cancer. Although risk factors often influence the risk of developing cancer, most do not directly cause cancer. Some people with several risk factors never develop cancer, while others with no known risk factors do. Knowing your risk factors and talking about them with your doctor may help you make more informed lifestyle and health care choices.

The risk factors for inflammatory breast cancer are the same as those for other forms of breast cancer. It is not known what specific factors can raise a person’s risk of inflammatory breast cancer. A family history of breast cancer in general may increase the risk of developing inflammatory breast cancer, but no specific genetic mutations or changes have been found for this type of breast cancer.

Prevention

Different factors cause different types of cancer. Researchers continue to look into what factors cause inflammatory breast cancer, including ways to prevent it. Although there is no proven way to completely prevent inflammatory breast cancer, you may be able to lower your risk. Talk with your health care team for more information about your personal risk of cancer. The methods used for preventing inflammatory breast cancer are similar to those used for other types of breast cancer. Learn more about breast cancer prevention.

The next section in this guide is Screening. It explains how tests may find cancer before signs or symptoms appear. Use the menu to choose a different section to read in this guide.

Breast Cancer - Inflammatory - Screening

Approved by the Cancer.Net Editorial Board, 06/2022

ON THIS PAGE: You will find out more about screening for inflammatory breast cancer. You will also learn the risks and benefits of screening. Use the menu to see other pages.

Screening is used to look for cancer before you have any symptoms or signs. Scientists have developed, and continue to develop, tests that can be used to screen a person for specific types of cancer. The overall goals of cancer screening are to:

  • Lower the number of people who die from the disease, or eliminate deaths from cancer altogether

  • Lower the number of people who develop the disease

The screening methods for inflammatory breast cancer are similar to those used for other types of breast cancer. Learn more about recommendations for breast cancer screening and the basics of cancer screening.

The next section in this guide is Symptoms and Signs. It explains what changes or medical problems inflammatory breast cancer can cause. Use the menu to choose a different section to read in this guide.

Breast Cancer - Inflammatory - Symptoms and Signs

Approved by the Cancer.Net Editorial Board, 06/2022

ON THIS PAGE: You will find out more about changes and other things that can signal a problem that may need medical care. Use the menu to see other pages.

Symptoms of inflammatory breast cancer may appear quickly and within a short amount of time of each other. Symptoms are changes that you can feel in your body. Signs are changes in something measured, like by taking your blood pressure or doing a lab test. Together, symptoms and signs can help describe a medical problem. Sometimes, people with inflammatory breast cancer do not have any of the symptoms and signs described below. Or, the cause of a symptom or sign may be a medical condition that is not cancer.

  • A red, swollen, or warm breast. This symptom is caused when the cancer cells block the lymph vessels in the skin of the breast. Because inflammatory breast cancer cells are located within the lymphatic system of the breast, the cells can spread to other parts of the body.

  • Skin or nipple changes, including ridges, puckering, or roughness on the skin. The pores of the skin may be more noticeable. These skin changes have been compared with the skin of an orange and may be called “peau d’orange.”

  • A lump in the breast, although often there is not a distinct lump.

  • Pain in the breast or nipple

  • Nipple discharge

If you are concerned about any changes you experience in your breast, please talk with your doctor. Your doctor will ask how long and how often you’ve been experiencing the symptom(s), in addition to other questions. This is to help figure out the cause of the problem, called a diagnosis.

If cancer is diagnosed, relieving symptoms is an important part of cancer care and treatment. Managing symptoms may also be called "palliative care" or "supportive care." It is often started soon after diagnosis and continued throughout treatment. Be sure to talk with your health care team about the symptoms you experience, including any new symptoms or a change in symptoms.

The next section in this guide is Diagnosis. It explains what tests may be needed to learn more about the cause of the symptoms. Use the menu to choose a different section to read in this guide.

Breast Cancer - Inflammatory - Diagnosis

Approved by the Cancer.Net Editorial Board, 06/2022

ON THIS PAGE: You will find a list of common tests, procedures, and scans that doctors use to find the cause of a medical problem. Use the menu to see other pages.

Doctors use many tests to find, or diagnose, cancer. They also do tests to learn if cancer has spread to another part of the body from where it started. If the cancer has spread, it is called metastasis. Doctors may also do tests to learn which treatments could work best.

For most types of cancer, a biopsy of the tumor is the only sure way for the doctor to know if an area of the body has cancer. In a biopsy, the doctor takes a small sample of tissue for testing in a laboratory. This is the most important step to make a diagnosis and to plan treatment. If a biopsy is not possible, the doctor may suggest other tests that will help make a diagnosis.

How inflammatory breast cancer is diagnosed

There are many tests used for diagnosing inflammatory breast cancer. Not all tests described here will be used for every person. Your doctor may consider these factors when choosing a diagnostic test:

  • The type of cancer suspected

  • Your signs and symptoms

  • Your age and general health

  • The results of earlier medical tests

Inflammatory breast cancer is usually diagnosed through a physical examination of the breast and nearby lymph nodes and based on a person’s symptoms. Breast imaging tests and a biopsy of the breast and/or skin are also needed to confirm a diagnosis of inflammatory breast cancer.

How inflammatory breast cancer is diagnosed

Breast imaging tests

Imaging tests show pictures of the inside of the body. They can show if cancer has spread.

  • Diagnostic mammography. A diagnostic mammogram is an x-ray of the breast. An x-ray is a way to create a picture of the structures inside of the body using a small amount of radiation. It is similar to a screening mammography, which is used to look for a possible breast tumor in people who have no symptoms. Diagnostic mammography is often used when a person is experiencing signs, such as nipple discharge or a new lump. It may also be used if something suspicious is found on a screening mammogram.

  • Ultrasound. An ultrasound uses high-frequency sound waves to create an image of the breast tissue. An ultrasound can distinguish between a solid mass, which may be cancer, and a fluid-filled cyst, which is usually not cancer.

  • Magnetic resonance imaging (MRI). An MRI uses magnetic fields, not x-rays, to produce detailed images of the body. An MRI can be used to measure the tumor’s size. A special dye called a contrast medium is given into the patient’s vein before the scan to help create a clear picture of the possible cancer. This dye can be injected into a patient’s vein or given as a pill or liquid to swallow. A breast MRI may be used after a diagnosis of breast cancer to check the other breast for cancer or to find out how much the disease has grown throughout the breast. It may also be used for screening, along with mammography, for those with a very high risk of developing breast cancer.

Surgical tests

Biopsy. A biopsy is the removal of a small amount of tissue for examination under a microscope. Other tests can suggest that cancer is present, but only a biopsy can make a definite diagnosis. A pathologist then analyzes the sample(s). A pathologist is a doctor who specializes in interpreting laboratory tests and evaluating cells, tissues, and organs to diagnose disease. There are different types of biopsies, classified by the technique and/or size of the needle used to collect the tissue sample.

  • A fine needle aspiration biopsy uses a thin needle to remove a small sample of cells.

  • A core needle biopsy uses a wider needle to remove a larger sample of tissue. This is usually the preferred way to find out whether an abnormality on a physical examination or an imaging test is cancer. For inflammatory breast cancer, there may be no single, main tumor, so more than 1 core biopsy may be needed to diagnose the cancer.

  • A vacuum-assisted biopsy removes several large cores of tissue. Local anesthesia, which is medication to block pain, is used to lessen a patient’s discomfort during the procedure.

  • A skin biopsy is often used to help diagnose inflammatory breast cancer, but it is not always needed. Inflammatory breast cancer cells can travel through lymph vessels in the skin, so a skin biopsy can help find out if there are inflammatory breast cancer cells in the skin.

  • A surgical biopsy removes the largest amount of tissue. This biopsy may be incisional or excisional. An incisional biopsy is the removal of part of the lump. An excisional biopsy is the removal of the entire lump. Because surgery is best done after a cancer is diagnosed, a surgical biopsy is usually not the recommended way to diagnose breast cancer. Most often, non-surgical core needle biopsies are recommended to diagnose breast cancer. This means that only 1 surgical procedure is needed to remove the tumor and to take samples of the lymph nodes. An incisional biopsy is rarely used to diagnose breast cancer, but it may be needed if the core needle biopsies (see above) were not helpful to diagnose the cancer.

  • An image-guided biopsy is used when a distinct lump cannot be felt, but an abnormality is seen with an imaging test, such as a mammogram. During this procedure, a needle is guided to the location with the help of an imaging technique, such as mammography, ultrasound, or MRI. A stereotactic biopsy is done using mammography to help guide the needle. A small metal clip may be put into the breast to mark where the biopsy sample was taken, in case the tissue is cancerous and more surgery is needed. This clip is usually titanium, so it will not cause problems with future imaging tests, but check with your doctor before you have additional imaging tests. An image-guided biopsy can be done using a fine needle, core, or vacuum-assisted biopsy (see above), depending on the amount of tissue being removed. This approach may be useful to diagnose inflammatory breast cancer, as imaging may help identify the best place to take a biopsy sample when a distinct mass is not felt.

  • Sentinel lymph node biopsy is a way to find out if there is cancer in the lymph nodes near the breast. This type of biopsy is not usually used for inflammatory breast cancer. The preferred way to examine lymph nodes for inflammatory breast cancer is with an axillary lymph node dissection. If there is cancer in the lymph nodes, the cancer is called “lymph node-positive breast cancer” or “node-positive.” If there is no cancer in the lymph nodes, the cancer is called “lymph node-negative breast cancer” or “node-negative.” Learn more about sentinel lymph node biopsy and axillary lymph node dissection in the Types of Treatment section.

Analyzing the biopsy sample

Analyzing the sample(s) removed during the biopsy helps your doctor learn about the specific features of a cancer and determine treatment options.

  • Tumor features. Examination of the tumor under the microscope is used to find out if it is invasive and has spread to the lymph nodes. Inflammatory breast cancer is always invasive.

  • Estrogen receptors (ER) and progesterone receptors (PR). Testing for ER and PR helps determine both the patient’s risk of recurrence and the type of treatment that is most likely to lower the risk of recurrence. As mentioned in the Introduction section, inflammatory breast cancer is often ER/PR negative. However, many inflammatory breast cancers are ER/PR positive. Learn about ER and PR testing recommendations from the American Society of Clinical Oncology (ASCO) and the College of American Pathologists (CAP).

  • Human epidermal growth factor receptor 2 (HER2). The HER2 status helps determine whether drugs that target the HER2 receptor might help treat the cancer. As mentioned in the Introduction section, inflammatory breast cancer is often HER2 negative but can sometimes have these receptors. Learn about recommendations for HER2 testing in the Diagnosis section of the Guide to Breast Cancer.

  • Grade. The tumor grade is also determined from the biopsy. The grade describes how much cancer cells look like healthy cells when viewed under a microscope. The doctor compares the cancerous tissue with healthy tissue. Healthy tissue usually contains many different types of cells grouped together. If the cancer looks similar to healthy tissue and has different cell groupings, it is called "well differentiated" or a "low-grade tumor." If the cancerous tissue looks very different from healthy tissue, it is called "poorly differentiated" or a "high-grade tumor." The cancer’s grade may help the doctor predict how quickly the cancer will spread. In general, the lower the tumor’s grade, the better the prognosis.

Your doctor may recommend additional laboratory tests on your tumor sample to identify specific genes, proteins, and other factors unique to the tumor. This helps your doctor find out the subtype of cancer.

Blood tests

Your doctor may also need to do blood tests to learn more about your health:

  • Complete blood count. A complete blood count (CBC) is used to measure the number of different types of cells, such as red blood cells and white blood cells, in a sample of a person’s blood. It is done to make sure that your bone marrow is functioning well.

  • Serum chemistry. Serum chemistry tests are often done to look at minerals in your blood, such as potassium and sodium. They also evaluate the health of your kidneys and liver.

  • Blood tumor marker tests. Serum tumor markers are tumor proteins in a person's blood. Higher levels of a serum tumor marker may be from cancer or a noncancerous condition. Tumor marker testing is typically used to monitor the growth of metastatic breast cancer, along with symptoms and imaging tests. Tumor marker tests are usually not needed for people without metastatic breast cancer and should not be used to monitor for a recurrence, as such testing does not appear to improve a patient’s chance of recovery.

Additional tests

Whether your doctor recommends additional imaging tests to find out if the cancer has spread depends on your medical history, symptoms, how much the disease has grown in the breast and lymph nodes, and the results of your physical examination. These tests are not recommended for all patients.

  • X-ray. An x-ray is a way to create a picture of the structures inside of the body using a small amount of radiation. A chest x-ray may be used to look for cancer that has spread from the breast to the lungs.

  • Bone scan. A bone scan may be used to look for spread of cancer to the bones. A radioactive dye or tracer is injected into a patient’s vein, and then the scan is performed several hours later using a special camera. The amount of radiation in the tracer is too low to be harmful. The tracer collects in areas of the bone that are healing, which occurs in response to damage from the cancer cells. The areas where the tracer collects appear lighter and stand out on the image compared to healthy bone. Some cancers do not cause the same healing response and will not show up on the bone scan. Areas of advanced arthritis or healing after a fracture will also show up on the image.

  • Computed tomography (CT or CAT) scan. A CT scan may be used to look for tumors in organs outside of the breast, such as the lung, liver, bone, and lymph nodes. A CT scan takes pictures of the inside of the body using x-rays taken from different angles. A computer combines these pictures into a detailed, 3-dimensional image that shows abnormalities, including most tumors. A CT scan can be used to measure the tumor’s size and find out if it is shrinking with treatment. A contrast dye may be injected into a patient’s vein before the scan to provide better detail.

  • Positron emission tomography (PET) or PET-CT scan. A PET scan is usually combined with a CT scan (see above), called a PET-CT scan. However, you may hear your doctor refer to this procedure just as a PET scan. A PET scan may be used to find out whether the cancer has spread to organs outside of the breast. A PET scan is a way to create pictures of organs and tissues inside the body. A small amount of a radioactive sugar substance is injected into a patient’s vein. This sugar substance is then taken up by cells that use the most energy because they are actively dividing. Because cancer cells tend to use energy actively, they absorb more of the radioactive substance. However, the amount of radiation in the substance is too low to be harmful. A scanner then detects this substance to produce images of the inside of the body. Areas that are most active appear as bright spots, and the intensity of the brightness can be measured to better describe these areas. A PET scan may also be used to measure the size of tumors and to determine the location of the bright spots more accurately. This test will also show abnormalities in the bone, similar to a bone scan.

After diagnostic tests are completed, your doctor will review the results with you. These results also help the doctor describe the amount of cancer in the body. This is called staging. If there are suspicious areas found outside of the breast, at least 1 of these areas may be biopsied if possible to confirm the diagnosis of cancer.

The next section in this guide is Stages. It explains the system doctors use to describe the extent of the disease. Use the menu to choose a different section to read in this guide.

Breast Cancer - Inflammatory - Stages

Approved by the Cancer.Net Editorial Board, 06/2022

ON THIS PAGE: You will learn about how doctors describe a cancer’s growth or spread. This is called the stage. Use the menu to see other pages.

What is cancer staging?

Staging is a way of describing where the cancer is located, how much the cancer has grown, and if or where it has spread. Doctors use diagnostic tests to find out the cancer's stage, so staging may not be complete until all the tests are finished. Knowing the stage helps the doctor recommend the best kind of treatment and can help predict a patient's prognosis, which is the chance of recovery. There are different stage descriptions for different types of cancer.

This page provides detailed information about the system used to find the stage of inflammatory breast cancer and the stage groups for inflammatory breast cancer, such as stage IIIB or stage IV.

TNM staging system

The most commonly used tool that doctors use to describe the stage is the TNM system. Doctors use the results from diagnostic tests and scans to answer these questions:

  • Tumor (T): How large is the primary tumor? Where is it located?

  • Node (N): Has the tumor spread to the lymph nodes? If so, where and to how many?

  • Metastasis (M): Has the cancer spread to other parts of the body? If so, where and how much?

The results are combined to determine the stage of cancer for each person. The stage provides a common way of describing the cancer so doctors can work together to plan the best treatments.

Staging can be clinical or pathological. Clinical staging is based on the results of tests done before surgery, which may include a physical examination, mammogram, ultrasound, and magnetic resonance imaging (MRI) scans. Pathological staging is based on the pathology results from the breast tissue and any lymph nodes removed during surgery. The results are usually available several days after surgery. In general, more importance is placed on the pathological stage than the clinical stage.

Return to top

Stage groups for inflammatory breast cancer

Doctors assign the stage of the cancer by combining the T, N, and M classifications (see above). Read about specific T, N, and M classifications in the Guide to Breast Cancer. Doctors also use other factors, such as tumor grade and the results of estrogen receptor (ER)/progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) testing, to determine the stage and your prognosis (see Diagnosis).

Inflammatory breast cancer is generally considered stage IIIB breast cancer when it is first diagnosed. It may be diagnosed as stage IV if it has spread outside the breast and lymph nodes. Read more about these stages below. To learn more about all stages of breast cancer, read the Guide to Breast Cancer.

Stage IIIB: The inflammatory breast cancer may or may not have spread to the axillary or internal mammary lymph nodes. It has not spread to other parts of the body (T4; N0, N1 or N2; M0).

Stage IIIC: The inflammatory breast cancer has spread to 10 or more axillary lymph nodes, the internal mammary lymph nodes, and/or the lymph nodes under the collarbone. It has not spread to other parts of the body (any T, N3, M0).

Stage IV (metastatic): The inflammatory breast cancer has spread to other organs, such as the bones, lungs, brain, liver, distant lymph nodes, or chest wall (any T, any N, M1). Learn more about metastatic breast cancer.

Recurrent: Recurrent cancer is cancer that has come back after treatment. A breast cancer recurrence can be either local, distant, or both. If the cancer does return, there will be another round of tests to learn about the extent of the recurrence. These tests and scans are often similar to those done at the time of the original diagnosis.

Return to top

Used with permission of the American College of Surgeons, Chicago, Illinois. The original and primary source for this information is the AJCC Cancer Staging Manual, Eighth Edition (2017), published by Springer International Publishing.

Information about the cancer’s stage will help the doctor recommend a specific treatment plan. The next section in this guide is Types of Treatment. Use the menu to choose a different section to read in this guide.

Breast Cancer - Inflammatory - Types of Treatment

Approved by the Cancer.Net Editorial Board, 06/2022

ON THIS PAGE: You will learn about the different types of treatments doctors use for people with inflammatory breast cancer. Use the menu to see other pages.

This section explains the types of treatments, also known as therapies, that are the standard of care for inflammatory breast cancer. “Standard of care” means the best treatments known. When making treatment plan decisions, you are encouraged to discuss with your doctor whether clinical trials are an option. A clinical trial is a research study that tests a new approach to treatment. Doctors learn through clinical trials whether a new treatment is safe, effective, and possibly better than the standard treatment. Clinical trials can test a new drug, a new combination of standard treatments, or new doses of standard drugs or other treatments. Clinical trials are an option for all stages of cancer. Your doctor can help you consider all your treatment options. Learn more about clinical trials in the About Clinical Trials and Latest Research sections of this guide.

How inflammatory breast cancer is treated

In cancer care, doctors specializing in different areas of cancer treatment work together to create a patient’s overall treatment plan that combines different types of treatments. This is called a multidisciplinary team. Cancer care teams include a variety of other health care professionals, such as physician assistants, nurse practitioners, oncology nurses, social workers, pharmacists, genetic counselors, nutritionists, and others.

Inflammatory breast cancer is considered a locally-advanced breast cancer and is typically treated with several types of treatment, including chemotherapy, surgery, radiation therapy, human epidermal growth factor receptor 2 (HER2) targeted therapy, and/or hormone therapy, as appropriate.

Inflammatory breast cancer treatment usually starts with chemotherapy. Chemotherapy before surgery is called neoadjuvant therapy or preoperative therapy. After chemotherapy, people with inflammatory breast cancer usually have surgery to remove the breast. Then, they receive radiation therapy to the chest wall and the nearby lymph nodes. If a patient has metastatic (stage IV) breast cancer when first diagnosed, the main treatment options are systemic therapies, such as chemotherapy. Surgery and/or radiation therapy are less commonly used.

Treatment options and recommendations depend on several factors, including the type and stage of cancer, possible side effects, and the patient’s preferences and overall health. Take time to learn about all of your treatment options and be sure to ask questions about things that are unclear. Talk with your doctor about the goals of each treatment and what you can expect while receiving the treatment. These types of talks are called “shared decision-making.” Shared decision-making is when you and your doctors work together to choose treatments that fit the goals of your care. Shared decision-making is particularly important for inflammatory breast cancer because there are different treatment options. Learn more about making treatment decisions.

The common types of treatments used for inflammatory breast cancer are described below. Your care plan may also include treatment for symptoms and side effects, an important part of cancer care.

Therapies using medication

The treatment plan may include medications to destroy cancer cells. Medication may be given through the bloodstream to reach cancer cells throughout the body. When a drug is given this way, it is called systemic therapy. Medication may also be given locally, which is when the medication is applied directly to the cancer or kept in a single part of the body. This treatment is generally prescribed by a medical oncologist, a doctor who specializes in treating cancer with medication.

Medications are often given through an intravenous (IV) tube placed into a vein using a needle or as a pill or capsule that is swallowed (orally). If you are given oral medications to take at home, be sure to ask your health care team about how to safely store and handle them.

The types of medications used for inflammatory breast cancer include:

  • Chemotherapy

  • Targeted therapy

  • Immunotherapy

  • Hormonal therapy

Each of these types of therapies is discussed below in more detail. A person may receive 1 type of medication at a time or a combination of medications given at the same time. They can also be given as part of a treatment plan that includes surgery and/or radiation therapy.

The medications used to treat cancer are continually being evaluated. Talking with your doctor is often the best way to learn about the medications prescribed for you, their purpose, and their potential side effects or interactions with other medications. It is also important to let your doctor know if you are taking any other prescription or over-the-counter medications or supplements. Herbs, supplements, and other drugs can interact with cancer medications, causing unwanted side effects or reduced effectiveness. Learn more about your prescriptions by using searchable drug databases.

Chemotherapy

Chemotherapy is the use of drugs to destroy cancer cells, usually by keeping the cancer cells from growing, dividing, and making more cells.

A chemotherapy regimen consists of a specific treatment schedule of drugs given at repeating intervals for a set number of times. Chemotherapy for inflammatory breast cancer is usually given before surgery, called preoperative or neoadjuvant chemotherapy. Sometimes additional chemotherapy is also given after chemotherapy, called adjuvant chemotherapy.

Chemotherapy for inflammatory breast cancer that has not spread outside of the breast and regional lymph nodes usually includes a combination of drugs.

Common drugs for non-metastatic inflammatory breast cancer may include:

  • Capecitabine (Xeloda)

  • Carboplatin (available as a generic drug)

  • Cyclophosphamide (available as a generic drug)

  • Docetaxel (Taxotere)

  • Doxorubicin (available as a generic drug)

  • Epirubicin (Ellence)

  • Fluorouracil (5-FU)

  • Methotrexate (Rheumatrex, Trexall)

  • Paclitaxel (Taxol)

  • Protein-bound paclitaxel (Abraxane)

Common chemotherapy combinations for inflammatory breast cancer may include:

  • AC or EC (doxorubicin and cyclophosphamide or epirubicin and cyclophosphamide) followed by T (paclitaxel or docetaxel)

  • TAC (docetaxel, doxorubicin, and cyclophosphamide)

Other chemotherapy combinations that may be used for inflammatory breast cancer include:

  • AC (doxorubicin and cyclophosphamide)

  • CAF (cyclophosphamide, doxorubicin, and 5-FU)

  • CEF (cyclophosphamide, epirubicin, and 5-FU)

  • CMF (cyclophosphamide, methotrexate, and 5-FU)

  • EC (epirubicin and cyclophosphamide)

  • TC (docetaxel and cyclophosphamide)

Treatments that target the HER2 receptor may be given with chemotherapy for HER2-positive breast cancer (see "Targeted therapy," below).

Immunotherapy may be given with chemotherapy for triple negative breast cancer (see "Immunotherapy," below).

The side effects of chemotherapy depend on the individual and the drug and dose used, but they can include fatigue, risk of infection, nausea and vomiting, numbness and tingling in the fingers and toes, hair loss, loss of appetite, and diarrhea or constipation. These side effects usually go away after treatment is finished. Long-term side effects may occur, such as nerve damage or fatigue, and, rarely, heart damage or secondary cancers.

Learn more about the basics of chemotherapy.

You can learn more about drugs used to treat metastatic inflammatory breast cancer in the Guide to Metastatic Breast Cancer.

Return to top

Targeted therapy

Targeted therapy is a treatment that targets the cancer’s specific genes, proteins, or the tissue environment that contributes to cancer growth and survival. These treatments are very focused, and they work differently than chemotherapy. This type of treatment blocks the growth and spread of cancer cells and limits damage to healthy cells.

Not all cancers have the same targets. To find the most effective treatment, your doctor may run tests to identify the genes, proteins, and other factors in the cancer. In addition, research studies continue to find out more about specific molecular targets and new treatments directed at them. Learn more about the basics of targeted treatments.

HER2 is a specialized protein found on breast cancer cells that controls cancer growth and spread. If an inflammatory breast cancer tests positive for HER2, targeted therapy will likely be an option for treatment along with standard chemotherapy.

HER2-positive inflammatory breast cancer is usually treated with medications that target HER2. The choice of which HER2-targeted drug to use depends on the cancer’s stage.

Commonly used HER2-targeting medications for breast cancer include:

  • Trastuzumab (Herceptin, Herzuma, Ogivri, Ontruzant, Hylecta)

  • Pertuzumab (Perjeta)

  • Ado-trastuzumab emtansine (Kadcyla)

  • Neratinib (Nerlynx)

HER2-targeted therapy is usually given in combination with chemotherapy, and then after chemotherapy ends. Common combination regimens for HER2-positive inflammatory breast cancer include:

  • AC-THP (doxorubicin, cyclophosphamide, paclitaxel, trastuzumab, pertuzumab)

  • TCHP (docetaxel, carboplatin, trastuzumab, pertuzumab)

Other combination regimens that may be used for HER2-positive inflammatory breast cancer include:

  • AC-TH (doxorubicin, cyclophosphamide, paclitaxel, trastuzumab)

  • TCH (docetaxel, carboplatin, trastuzumab)

If a patient has no cancer still remaining in the breast at the time of surgery, they will generally be recommended to continue to receive trastuzumab with or without pertuzumab every 3 weeks until completion of 1 year of therapy (11 to 14 doses). However, if a patient is found to have cancer still remaining in the breast at the time of surgery, they will generally be recommended to receive ado-trastuzumab emtansine every 3 weeks for 14 doses.

Patients receiving HER2-targeted therapy have a small risk of developing heart problems. This risk is increased if they also have other risk factors for heart disease. Heart problems do not always go away, but they are usually treatable with medication. Talk with your doctor about possible side effects for a specific medication and how they can be managed.

Bone modifying drugs

Bone modifying drugs block bone destruction and help strengthen the bone. They may be used to prevent cancer from recurring in the bone or to treat cancer that has spread to the bone. Bone modifying drugs are not a substitute for standard anti-cancer treatments. Certain types of bone modifying drugs are also used in low doses to prevent and treat osteoporosis, which is the thinning of the bones.

The drugs used to block bone destruction and present breast cancer recurrence in the bone are:

  • Bisphosphonates. These block the cells that destroy bone, called osteoclasts.

All people with breast cancer who have been through menopause, including people with inflammatory breast cancer, should have a discussion with their doctor whether bisphosphonates are right for them. Several factors affect this decision, including your risk of recurrence, the side effects of treatment, the cost of treatment, your preferences, and your overall health.

If treatment with bisphosphonates is recommended, ASCO recommends starting within 3 months after surgery or within 2 months after adjuvant chemotherapy. This may include treatment with clodronate (multiple brand names), ibandronate (Boniva), or zoledronic acid (Reclast, Zometa). Clodronate is not available in the United States.

This information is based on the ASCO and Ontario Health (Cancer Care Ontario) guideline, “Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer.” Please note that this link takes you to another ASCO website.

Other types of targeted therapy for breast cancer

You may have other targeted therapy options for breast cancer treatment, depending on several factors. The following drugs are used for the treatment of non-metastatic breast cancer in people with an inherited BRCA1 or BRCA2 gene mutation and a high risk of breast cancer recurrence.

  • Olaparib (Lynparza). This is a type of oral drug called a PARP inhibitor, which destroys cancer cells by preventing them from fixing damage to the cells. ASCO recommends using olaparib to treat early-stage, HER2-negative breast cancer in people with an inherited BRCA1 or BRCA2 gene mutation and a high risk of breast cancer recurrence. Adjuvant olaparib should be given for 1 year following the completion of chemotherapy, surgery, and radiation therapy (if needed).

  • Abemaciclib (Verzenio). This oral drug, called a CDK4/6 inhibitor, targets a protein in breast cancer cells called CDK4/6, which may stimulate cancer cell growth. It is approved as treatment in combination with hormonal therapy (tamoxifen or an aromatase inhibitor; see "Hormonal therapy" below) to treat people with hormone receptor-positive, HER2-negative, early breast cancer that has spread to the lymph nodes and has a high risk of recurrence. ASCO recommends consideration of 2 years of treatment with abemaciclib combined with 5 or more years of hormonal therapy for patients meeting these criteria, including for people whose cancer has a Ki-67 score higher than 20% (see Diagnosis). Treatment should be given following the completion of chemotherapy, surgery, and radiation therapy.

You can learn more about drugs used to treat metastatic inflammatory breast cancer in the Guide to Metastatic Breast Cancer.

Return to top

Immunotherapy

Immunotherapy uses the body's natural defenses to fight cancer by improving your immune system’s ability to attack cancer cells. The following drug can be used in combination with neoadjuvant chemotherapy for treatment of inflammatory breast cancer that is triple negative.

  • Pembrolizumab (Keytruda). This is a type of immunotherapy that is approved by the FDA to treat high-risk, early-stage, triple-negative breast cancer in combination with chemotherapy before surgery. It then is given alone following surgery.

Different types of immunotherapy can cause different side effects. Common side effects include skin rashes, flu-like symptoms, diarrhea, and weight changes. Other severe but less common side effects can also occur. Talk with your doctor about possible side effects of the immunotherapy recommended for you. Learn more about the basics of immunotherapy.

Return to top

Hormonal therapy

Hormonal therapy, also called endocrine therapy, is an effective treatment for breast cancer that tests positive for either estrogen or progesterone receptors (called ER positive or PR positive; see Introduction) in all stages of breast cancer. This type of breast cancer uses hormones to fuel its growth. Blocking the hormones may slow the growth of the cancer and destroy the cancer cells. Hormone therapy is typically recommended for hormone receptor-positive cancer after chemotherapy and radiation therapy or as treatment for metastatic breast cancer.

Hormonal therapy is usually taken for at least 5 years. It may be taken for up to 10 years, especially when there is a higher risk of the cancer returning. How long to continue hormonal therapy depends on the stage of cancer, the risk of it returning, and any side effects you are experiencing.

Hormonal therapy for inflammatory breast cancer is typically started either during or after adjuvant radiation therapy (see below). Hormonal therapy options include:

  • Tamoxifen (available as a generic) blocks estrogen from binding to breast cancer cells. It is a hormonal therapy that can be used before or after menopause.

  • Aromatase inhibitors (AIs, all available as generics) decrease the amount of estrogen made by the body. These drugs include anastrozole (Arimidex), exemestane (Aromasin), and letrozole (Femara). AIs are effective in treating breast cancer in postmenopausal people or premenopausal people who are also receiving ovarian suppression.

  • Ovarian suppression refers to the use of drugs or surgery to stop the ovaries from producing estrogen. It may be used in addition to another type of hormonal therapy for people who have not been through menopause. There are 2 methods used for ovarian suppression:

    • Drugs called gonadotropin or luteinizing releasing hormone (GnRH or LHRH) analogs that stop the ovaries from making estrogen. Goserelin (Zoladex) and leuprolide (Eligard, Lupron) are GnRH and LHRH agonists that stop the ovaries from making estrogen for 1 to 3 months.

    • Surgery to remove the ovaries, which permanently stops estrogen production.

Side effects of hormonal therapy can include hot flashes, decreased sexual desire or ability, body aches and stiffness, and mood swings. Find additional information about hormone therapy in the breast cancer treatment section. Learn more about the basics of hormone therapy.

Return to top

Surgery

Surgery for breast cancer involves the removal of the tumor in an operation. Surgery is also used to examine the surrounding axillary or underarm lymph nodes. A surgical oncologist is a doctor who specializes in treating cancer using surgery.

Because inflammatory breast cancer is usually located throughout the breast and the lymphatic vessels in the skin, starting with surgery first may not be successful to remove all of the cancer with negative margins. A negative margin means that there is no cancer left at the edges of the tissue removed during surgery. Any cancer left behind during surgery increases the chances of recurrence in the breast and affects healing. Because of this, chemotherapy is typically given first for inflammatory breast cancer to shrink and destroy the cancer in the breast, improving the chance that surgery will be successful.

The usual surgical treatment for inflammatory breast cancer is the removal of the entire breast, a procedure called a mastectomy. Reconstructive surgery of the breast after mastectomy is discussed below.

Before surgery, talk with your health care team about the possible side effects from the specific surgery you will have. Learn more about the basics of cancer surgery.

Lymph node removal and analysis

It is important to find out whether any of the lymph nodes near the breast contain cancer. This information is used to determine treatment and prognosis.

  • Sentinel lymph node biopsy. In a sentinel lymph node biopsy, the surgeon finds and removes a small number of lymph nodes from under the arm that receive lymph drainage from the breast. The pathologist then examines these lymph nodes for cancer cells. In general, a sentinel lymph node biopsy is not appropriate for inflammatory breast cancer, and an axillary lymph node dissection is preferred (see below).

  • Axillary lymph node dissection. In an axillary lymph node dissection, the surgeon removes many lymph nodes from under the arm. Then, a pathologist examines these lymph nodes for cancer cells. The actual number of lymph nodes removed varies from person to person. An axillary lymph node dissection is the preferred way to evaluate the axillary lymph nodes of a person with inflammatory breast cancer.

Reconstructive or plastic surgery

After a mastectomy, a patient may wish to consider breast reconstruction, which is surgery to rebuild the breast. Breast reconstruction is performed by a reconstructive plastic surgeon.

There are many methods to reconstruct the breast. It may be done with tissue from another part of the body or with synthetic or artificial implants. Certain options may be preferred for inflammatory breast cancer because radiation therapy (see below) is almost always needed. Talk with your doctor for more information and learn more about reconstruction options.

Return to top

Radiation therapy

Radiation therapy is the use of high-energy x-rays or other particles to destroy cancer cells. A doctor who specializes in giving radiation therapy to treat cancer is called a radiation oncologist. The most common type of radiation treatment is called external-beam radiation therapy, which is radiation given from a machine outside the body.

A radiation therapy regimen, or schedule, usually consists of a specific number of treatments given over a set period of time. Adjuvant radiation therapy is radiation treatment after surgery. It is effective in reducing the chance of breast cancer returning in both the breast and the chest wall. Adjuvant radiation therapy is nearly always recommended for people with inflammatory breast cancer after mastectomy because of the high risk of cancer cells remaining in the chest wall.

Standard radiation therapy after a mastectomy is given to the chest wall for 5 days (Monday through Friday) for 5 to 6 weeks.

Standard radiation therapy after a lumpectomy is external-beam radiation therapy given daily. This usually includes radiation therapy to the whole breast for several weeks, depending on whether the cancer had spread to the lymph nodes. It is then followed by a more focused treatment to the area where the tumor was located in the breast for the remaining treatments. This focused part of the treatment, called a boost, is standard for people with invasive breast cancer to reduce the risk of a recurrence in the breast.

If there is evidence of cancer in the underarm lymph nodes, radiation therapy may also be given to the lymph node areas in the neck or underarm near the breast or chest wall. There has been growing interest in newer radiation regimens to shorten the length of treatment from 6 to 7 weeks to 3 to 4 weeks. However, these regimens have not been studied in people with inflammatory breast cancer. As always, talk with your doctor about your options for radiation therapy, as well as the risks and benefits of these options.

Radiation therapy can cause side effects, including fatigue, swelling of the breast, and skin changes. Skin changes may include redness, discoloration, and pain or burning, sometimes with blistering or peeling. Very rarely, a small amount of the lung can be affected by the radiation, causing pneumonitis, a radiation-related inflammation of the lung tissue. This risk depends on the size of the area that received radiation therapy. However, this tends to heal with time. In the past, with older equipment and radiation therapy techniques, people who received treatment for breast cancer on the left side of the body had a small increase in the long-term risk of heart disease. Modern techniques are now able to spare most of the heart from the effects of radiation therapy.

Learn more about the basics of radiation therapy.

Return to top

Physical, emotional, and social effects of cancer

Cancer and its treatment cause physical symptoms and side effects, as well as emotional, social, and financial effects. Managing all of these effects is called palliative care or supportive care. It is an important part of your care that is included along with treatments intended to slow, stop, or eliminate the cancer.

Palliative care focuses on improving how you feel during treatment by managing symptoms and supporting patients and their families with other, non-medical needs. Any person, regardless of age or type and stage of cancer, may receive this type of care. And it often works best when it is started right after a cancer diagnosis. People who receive palliative care along with treatment for the cancer often have less severe symptoms, better quality of life, and report that they are more satisfied with treatment.

Palliative treatments vary widely and often include medication, nutritional changes, relaxation techniques, emotional and spiritual support, and other therapies. You may also receive palliative treatments similar to those meant to get rid of the cancer, such as chemotherapy, surgery, or radiation therapy.

Before treatment begins, talk with your doctor about the goals of each treatment in the recommended treatment plan. You should also talk about the possible side effects of the specific treatment plan and palliative care options. Many patients also benefit from talking with a social worker and participating in support groups. Ask your doctor about these resources, too.

During treatment, your health care team may ask you to answer questions about your symptoms and side effects and to describe each problem. Be sure to tell the health care team if you are experiencing a problem. This helps the health care team treat any symptoms and side effects as quickly as possible. It can also help prevent more serious problems in the future.

Learn more about the importance of tracking side effects in another part of this guide. Learn more about palliative care in a separate section of this website.

Return to top

Metastatic inflammatory breast cancer

If cancer has spread to another part in the body from where it started, it is called metastatic cancer. If this happens, it is a good idea to talk with doctors who have experience in treating it. Doctors can have different opinions about the best standard treatment plan. Clinical trials might also be an option. Learn more about getting a second opinion before starting treatment, so you are comfortable with your chosen treatment plan.

Your treatment plan may include a combination of the treatments discussed above, or additional treatment options that are only used to treat metastatic breast cancer. However, surgery and radiation therapy may be used more often to manage symptoms in other parts of the body than to treat the cancer. Palliative care will also be important to help relieve symptoms and side effects.

For most people, a diagnosis of metastatic cancer is very stressful and difficult. You and your family are encouraged to talk about how you feel with doctors, nurses, social workers, or other members of your health care team. It may also be helpful to talk with other patients, such as through a support group or other peer support program.

Return to top

Finishing treatment and the chance of recurrence

For patients with stage III inflammatory breast cancer, when treatment ends, a period many call "post-treatment survivorship" begins. After treatment, people can feel uncertain and worry that the cancer may come back. While many patients never have the disease return, it is important to talk with your doctor about the possibility of the cancer returning. Understanding your risk of recurrence and the treatment options may help you feel more prepared if the cancer does return. Learn more about coping with the fear of recurrence.

If the cancer returns after the original treatment, it is called recurrent cancer. It may come back in the same place (called a local recurrence), nearby (locoregional recurrence), or in another place (distant recurrence or metastatic disease).

If a recurrence happens, a new cycle of testing will begin again to learn as much as possible about it. After this testing is done, you and your doctor will talk about the treatment options. Often the treatment plan will include the treatment types described above, such as chemotherapy, surgery, and radiation therapy, but they may be used in a different combination or given at a different pace. Your doctor may suggest clinical trials that are studying new ways to treat recurrent inflammatory breast cancer. Whichever treatment plan you choose, palliative care will be important for relieving symptoms and side effects.

People with recurrent cancer sometimes experience emotions such as disbelief or fear. You are encouraged to talk with your health care team about these feelings and ask about support services to help you cope. Learn more about dealing with cancer recurrence.

Return to top

If treatment does not work

Recovery from breast cancer is not always possible. If the cancer cannot be cured or controlled, the goals of care may switch to focusing on helping a person live as well as possible with the cancer.

This diagnosis is stressful, and for some people, advanced cancer may be difficult to discuss. However, it is important to have open and honest conversations with your health care team to express your feelings, preferences, and concerns. The health care team has special skills, experience, and knowledge to support patients and their families and is there to help. Making sure a person is physically comfortable and emotionally supported is extremely important.

People who have advanced cancer and who are expected to live less than 6 months may want to consider hospice care. Hospice care is designed to provide the best possible quality of life for people who are near the end of life. You and your family are encouraged to talk with the health care team about hospice care options, which include hospice care at home, a special hospice center, or other health care locations. Nursing care and special equipment can make staying at home a workable option for many families. Learn more about advanced cancer care planning.

After the death of a loved one, many people need support to help them cope with the loss. Learn more about grief and loss.

Return to top

The next section in this guide is About Clinical Trials. It offers more information about research studies that are focused on finding better ways to care for people with cancer. Use the menu to choose a different section to read in this guide.

Breast Cancer - Inflammatory - About Clinical Trials

Approved by the Cancer.Net Editorial Board, 06/2022

ON THIS PAGE: You will learn more about clinical trials, which are the main way that new medical approaches are studied to see how well they work. Use the menu to see other pages.

What are clinical trials?

Researchers are always looking for better ways to care for people with inflammatory breast cancer. To make scientific advances, doctors create research studies involving volunteers, called clinical trials. Every drug that is now approved by the U.S. Food and Drug Administration (FDA) was tested in clinical trials. 

Clinical trials are used for all types and stages of inflammatory breast cancer. Many focus on new treatments to learn if a new treatment is safe, effective, and possibly better than the existing treatments. These types of studies evaluate new drugs, different combinations of treatments, new approaches to radiation therapy or surgery, and new methods of treatment.

People who participate in clinical trials can be some of the first to get a treatment before it is available to the public. However, there are some risks with a clinical trial, including possible side effects and the chance that the new treatment may not work. People are encouraged to talk with their health care team about the pros and cons of joining a specific study. Clinical trials are used for all types and stages of inflammatory breast cancer. 

Some clinical trials study new ways to relieve symptoms and side effects from breast cancer treatment. Others study ways to manage the late effects that may happen a long time after treatment. Talk with your doctor about clinical trials for symptoms and side effects.

Deciding to join a clinical trial

People decide to participate in clinical trials for many reasons. For some, a clinical trial is the best treatment option available. Because standard treatments are not perfect, patients are often willing to face the added uncertainty of a clinical trial in the hope of a better result. Others volunteer for clinical trials because they know that these studies are a way to contribute to the progress in treating inflammatory breast cancer. Even if they do not benefit directly from the clinical trial, their participation may benefit future people with inflammatory breast cancer.

Insurance coverage and the costs of clinical trials differ by location and by study. In some programs, some of the expenses from participating in the clinical trial are reimbursed. In others, they are not. It is important to talk with the research team and your insurance company first to learn if and how your treatment in a clinical trial will be covered. Learn more about health insurance coverage of clinical trials.

Sometimes people have concerns that, in a clinical trial, they may receive no treatment by being given a placebo or a “sugar pill.” When used, placebos are usually combined with standard treatment in most cancer clinical trials. Study participants will always be told when a placebo is used in a study. Find out more about placebos in cancer clinical trials.

Patient safety and informed consent

To join a clinical trial, people must participate in a process known as informed consent, which is led by a doctor and the research team. During informed consent, the doctor should:

  • Describe all of the treatment options so that the person understands how the new treatment differs from the standard treatment.

  • List all of the risks of the new treatment, which may or may not be different from the risks of standard treatment.

  • Explain what will be required of each person to participate in the clinical trial, including the number of doctor visits, tests, and the schedule of treatment.

  • Describe the purposes of the clinical trial and what researchers are trying to learn.

Clinical trials also have certain rules called “eligibility criteria” that help structure the research and keep patients safe. You and the research team will carefully review these criteria together. You will need to meet all of the eligibility criteria in order to participate in a clinical trial. Learn more about eligibility criteria in clinical trials.

People who participate in a clinical trial may stop participating at any time for personal or medical reasons. This may include that the new treatment is not working or there are serious side effects. Clinical trials are also closely monitored by experts who watch for any problems with each study. It is important that people participating in a clinical trial talk with their doctor and researchers about who will be providing their treatment and care during the clinical trial, after the clinical trial ends, and/or if they choose to leave the clinical trial before it ends.

Finding a clinical trial

Research through clinical trials is ongoing for all types of cancer. For specific topics being studied for inflammatory breast cancer, learn more in the Latest Research section.

Cancer.Net offers more information about cancer clinical trials in other areas of the website, including a complete section on clinical trials and places to search for clinical trials for a specific type of cancer.

PRE-ACT, Preparatory Education About Clinical Trials

In addition, you can find a free video-based educational program about cancer clinical trials in another section of this website.

The next section in this guide is Latest Research. It explains areas of scientific research for inflammatory breast cancer. Use the menu to choose a different section to read in this guide.

Breast Cancer - Inflammatory - Latest Research

Approved by the Cancer.Net Editorial Board, 06/2022

ON THIS PAGE: You will read about the scientific research being done to learn more about inflammatory breast cancer and how to treat it. Use the menu to see other pages.

Doctors are working to learn more about inflammatory breast cancer, ways to prevent it, how to best treat it, and how to provide the best care to people diagnosed with this disease. The following areas of research may include new options for patients through clinical trials. Always talk with your doctor about the best diagnostic and treatment options for you.

  • New drugs and treatment combinations. There is interest in treating inflammatory breast cancer with specific drug combinations or combinations of drugs and radiation therapy that might help keep the cancer from returning. For advanced disease, treatments that include new targeted therapies or drugs that affect the immune system called immunotherapy are being studied.

  • Palliative care/supportive care. Clinical trials are underway to find better ways of reducing symptoms and side effects of current inflammatory breast cancer treatments to improve comfort and quality of life for patients.

Looking for More About the Latest Research?

If you would like more information about the latest areas of research in inflammatory breast cancer, explore these related items that take you outside of this guide:

The next section in this guide is Coping with Treatment. It offers some guidance on how to cope with the physical, emotional, social, and financial changes that cancer and its treatment can bring. Use the menu to choose a different section to read in this guide.

Breast Cancer - Inflammatory - Coping With Treatment

Approved by the Cancer.Net Editorial Board, 06/2022

ON THIS PAGE: You will learn more about coping with the physical, emotional, social, and financial effects of cancer and its treatment. Use the menu to see other pages.

Every cancer treatment can cause side effects or changes to your body and how you feel. For many reasons, people do not experience the same side effects even when they are given the same treatment for the same type of cancer. This can make it hard to predict how you will feel during treatment.

As you prepare to start cancer treatment, it is normal to fear treatment-related side effects. It may help to know that your health care team will work to prevent and relieve side effects. This part of cancer treatment is called palliative care or supportive care. It is an important part of your treatment plan, regardless of your age or the stage of disease.

Coping with physical side effects

Common physical side effects from each treatment option for inflammatory breast cancer are described in the Types of Treatment section. Learn more about side effects of cancer and its treatment, along with ways to prevent or control them. Changes to your physical health depend on several factors, including the cancer’s stage, the length and dose of treatment, and your general health.

Talk with your health care team regularly about how you are feeling. It is important to let them know about any new side effects or changes in existing side effects. If they know how you are feeling, they can find ways to relieve or manage your side effects to help you feel more comfortable and potentially keep any side effects from worsening.

You may find it helpful to keep track of your side effects so it is easier to talk about any changes with your health care team. Learn more about why tracking side effects is helpful.

Sometimes, side effects can last after treatment ends. Doctors call these long-term side effects. Examples of long-term side effects include swelling of the arm or breast, called lymphedema, and numbness and tingling in the fingers and toes, called neuropathy. Side effects that occur months or years after treatment are called late effects. Examples of late effects include heart damage or a second type of cancer from treatment for the breast cancer.

Treating long-term side effects and late effects is an important part of survivorship care. Learn more about these long-term side effects and late effects by reading the Follow-Up Care and Monitoring section of this guide or talking with your doctor.

Coping with emotional and social effects

You can have emotional and social effects after a cancer diagnosis. This may include dealing with a variety of emotions, such as sadness, anxiety, or anger, or managing your stress level. Sometimes, people find it difficult to express how they feel to their loved ones. Some have found that talking to an oncology social worker, counselor, or member of the clergy can help them develop more effective ways of coping and talking about cancer.

You can also find coping strategies for emotional and social effects in a separate section of this website. This section includes many resources for finding support and information to meet your needs.

Coping with the costs of cancer

Cancer treatment can be expensive. It may be a source of stress and anxiety for people with cancer and their families. In addition to treatment costs, many people find they have extra, unplanned expenses related to their care. For some people, the high cost of medical care stops them from following or completing their cancer treatment plan. This can put their health at risk and may lead to higher costs in the future. Patients and their families are encouraged to talk about financial concerns with a member of their health care team. Learn more about managing financial considerations in a separate part of this website.

Coping with barriers to care

Some groups of people experience different rates of new cancer cases and experience different outcomes from their cancer diagnosis. These differences are called “cancer disparities.” Disparities are caused in part by real-world barriers to quality medical care and social determinants of health, such as where a person lives and whether they have access to food and health care. Cancer disparities more often negatively affect racial and ethnic minorities, people with fewer financial resources, sexual and gender minorities (LGBTQ+), adolescent and young adult populations, older adults, and people who live in rural areas or other underserved communities.

If you are having difficulty getting the care you need, talk with a member of your health care team or explore other resources that help support medically underserved people.

Talking with your health care team about side effects

Before starting treatment, talk with your doctor about possible side effects. Ask:

  • Which side effects are most likely?

  • When are they likely to happen?

  • What can we do to prevent or relieve them?

  • When and who should we call about side effects?

Be sure to tell your health care team about any side effects that happen during treatment and afterward, too. Tell them even if you do not think the side effects are serious. This discussion should include physical, emotional, social, and financial effects of cancer.

Caring for a loved one with cancer

Family members and friends often play an important role in taking care of a person with inflammatory breast cancer. This is called being a caregiver. Caregivers can provide physical, practical, and emotional support to the patient, even if they live far away. Being a caregiver can also be stressful and emotionally challenging. One of the most important tasks for caregivers is caring for themselves.

Caregivers may have a range of responsibilities on a daily or as-needed basis, including:

  • Providing support and encouragement

  • Talking with the health care team

  • Giving medications

  • Helping manage symptoms and side effects

  • Coordinating medical appointments

  • Providing a ride to and from appointments

  • Assisting with meals

  • Helping with household chores

  • Handling insurance and billing issues

A caregiving plan can help caregivers stay organized and help identify opportunities to delegate tasks to others. It may be helpful to ask the health care team how much care will be needed at home and with daily tasks during and after treatment. Use this 1-page fact sheet to help make a caregiving action plan. This free fact sheet is available as a PDF, so it is easy to print.

Learn more about caregiving or read the ASCO Answers Guide to Caring for a Loved One With Cancer in English or Spanish.

Looking for More on How to Track Side Effects?

Cancer.Net Mobile app symptom tracker

Cancer.Net offers several resources to help you keep track of your symptoms and side effects. Please note that these links will take you to other sections of Cancer.Net:

  • Cancer.Net Mobile: The free Cancer.Net mobile app allows you to securely record the time and severity of symptoms and side effects.

  • ASCO Answers Managing Pain: Get this 32-page booklet about the importance of pain relief that includes a pain tracking sheet to help patients record how pain affects them. The free booklet is available as a PDF, so it is easy to print.

  • ASCO Answers Fact Sheets: Read 1-page fact sheets on anxiety and depression, constipation, diarrhea, and rash that provide a tracking sheet to record details about the side effect. These free fact sheets are available as a PDF, so they are easy to print, fill out, and give to your health care team.

The next section in this guide is Follow-Up Care and Monitoring. It explains the importance of checkups after you finish cancer treatment. Use the menu to choose a different section to read in this guide.

Breast Cancer - Inflammatory - Follow-Up Care and Monitoring

Approved by the Cancer.Net Editorial Board, 06/2022

ON THIS PAGE: You will read about your medical care after cancer treatment is completed and why this follow-up care is important. Use the menu to see other pages.

Care for people diagnosed with cancer does not end when active treatment has finished. Your health care team will continue to check that the cancer has not come back, manage any side effects, and monitor your overall health. This is called follow-up care.

Your follow-up care may include regular physical examinations, medical tests, or both. Doctors want to keep track of your recovery in the months and years ahead. In some instances, people may be able to visit a survivorship clinic that specializes in the post-treatment needs of people diagnosed with breast cancer. The American Society of Clinical Oncology (ASCO) offers its full recommendations for follow-up care for breast cancer survivors in a separate article.

Cancer rehabilitation may be recommended, and this could mean any of a wide range of services, such as physical therapy, occupational therapy, career counseling, pain management, nutritional planning, and/or emotional counseling. The goal of rehabilitation is to help people regain control over many aspects of their lives and remain as independent as possible. Learn more about cancer rehabilitation.

Learn more about the importance of follow-up care.

Watching for recurrence

One goal of follow-up care is to check for a recurrence, which means that the cancer has come back. Cancer recurs because small areas of cancer cells may remain undetected in the body. Over time, these cells may increase in number until they show up on test results or cause signs or symptoms.

During follow-up care, a doctor familiar with your medical history can give you personalized information about your risk of recurrence. Breast cancer can come back in the breast or other areas of the body. Generally, a recurrence is found when a person has new symptoms or an abnormal finding on physical examination. The symptoms depend on where the cancer has recurred and may include:

  • A new lump in the breast, under the arm, or along the chest wall

  • Bone pain or fractures

  • Headaches or seizures

  • Chronic coughing or trouble breathing

  • Extreme fatigue

  • Feeling ill

Your doctor will ask specific questions about your health at follow-up visits. It is important to share how you are feeling at those visits and ask any questions you may have about your health or follow-up care plan.

The anticipation before having a follow-up visit or waiting for test results may add stress to you or a family member. This is sometimes called "scanxiety." Learn more about how to cope with this type of stress.

Managing long-term and late side effects

Most people expect to have side effects when receiving treatment. However, it is often surprising to survivors that some side effects may linger beyond the treatment period. These are called long-term side effects. Other side effects called late effects may develop months or even years after treatment has ended. Long-term and late effects can include both physical and emotional changes.

  • Long-term effects of surgery. After a mastectomy, the chest may be scarred and have a different shape or size than before surgery. If lymph nodes were removed as part of the surgery or affected by treatment, a condition called lymphedema may develop. Lymphedema causes swelling of the hand, arm, breast, and/or chest wall, and it is a lifelong risk for patients.

  • Long-term effects of radiation therapy. Some patients experience breathlessness, a dry cough, and/or chest pain 2 to 3 months after finishing radiation therapy because the treatment can cause swelling and a hardening or thickening of the lungs called fibrosis. These symptoms may seem similar to the symptoms of pneumonia but do not go away with antibiotics. The symptoms can be treated with medications called steroids. Most patients fully recover with treatment. Talk with your doctor if you develop any new symptoms after radiation therapy or if the side effects are not going away.

  • Long-term effects of trastuzumab and/or chemotherapy. Patients who received trastuzumab or certain types of chemotherapy called anthracyclines may be at risk of heart problems. Talk with your doctor about the best ways to check for heart problems. Patients treated with chemotherapy also have a risk of other long-term side effects, such as menopausal symptoms, fatigue, chemobrain, permanent numbness and tingling of the fingers and toes, and weight gain.

  • Long-term effects of hormonal therapy. Patients who take hormonal therapy for many years can have menopausal symptoms such as hot flashes and vaginal dryness. Tell your doctor or nurse if you notice any abnormal vaginal bleeding or other new symptoms, as you may need additional tests to learn more about the cause. People who are taking an aromatase inhibitor (AI), such as anastrozole, exemestane, or letrozole, should have a bone density test periodically during treatment since these drugs may cause some bone weakness or bone loss, which increases the risk of breaking a bone. In addition, AIs can sometimes cause aches, pains, and stiffness during treatment. Talk with your doctor about what you can do to manage these symptoms if you experience them.

Talk with your doctor about your risk of developing such side effects based on your diagnosis, your individual treatment plan, and your overall health. If you had a treatment known to cause specific late effects, you may have certain physical examinations, scans, or blood tests to help find and manage them.

Keeping personal health records

You and your doctor should work together to develop a personalized follow-up care plan. Be sure to discuss any concerns you have about your future physical or emotional health. ASCO offers forms to help keep track of the cancer treatment you received and develop a survivorship care plan when treatment is completed.

This is also a good time to talk with your doctor about who will lead your follow-up care. Some survivors continue to see their oncologist, while others transition back to the care of their primary care doctor or another health care professional. This decision depends on several factors, including the type and stage of cancer, side effects, health insurance rules, and your personal preferences.

If a doctor who was not directly involved in your cancer care will lead your follow-up care, be sure to share your cancer treatment summary and survivorship care plan with them and with all future health care providers. Details about your cancer treatment are very valuable to the health care professionals who will care for you throughout your lifetime.

The next section in this guide is Survivorship. It describes how to cope with challenges in everyday life after a cancer diagnosis. Use the menu to choose a different section to read in this guide.

Breast Cancer - Inflammatory - Survivorship

Approved by the Cancer.Net Editorial Board, 06/2022

ON THIS PAGE: You will read about how to cope with challenges in everyday life after a cancer diagnosis. Use the menu to see other pages.

What is survivorship?

The word “survivorship” is complicated because it means different things to different people. Common definitions include:

  • Having no signs of cancer after finishing treatment.

  • Living with, through, and beyond cancer. According to this definition, cancer survivorship begins at diagnosis and continues during treatment and through the rest of a person’s life.

For some, even the term “survivorship” does not feel right, and they prefer to use different language to describe and define their experience. Sometimes extended treatment will be used for months or years to manage or control cancer. Living with cancer indefinitely is not easy, and the health care team can help you manage the challenges that come with it. Everyone has to find their own path to name and navigate the changes and challenges that are the results of their cancer diagnosis and treatment.

Survivors may experience a mixture of feelings, including joy, concern, relief, guilt, and fear. Some people say they appreciate life more after a cancer diagnosis and have gained a greater acceptance of themselves. Others become very anxious about their health and uncertain about coping with everyday life. Feelings of fear and anxiety may still occur as time passes, but these emotions should not be a constant part of your daily life. If they persist, be sure to talk with a member of your health care team.

Survivors may feel some stress when their frequent visits to the health care team end after completing treatment. Often, relationships built with the cancer care team provide a sense of security during treatment, and people miss this source of support. This may be especially true when new worries and challenges surface over time, such as any late effects of treatment, emotional challenges including fear of recurrence, sexual health and fertility concerns, and financial and workplace issues.

Every survivor has individual concerns and challenges. With any challenge, a good first step is being able to recognize your fears and talk about them. Effective coping requires:

  • Understanding the challenge you are facing

  • Thinking through solutions

  • Asking for and allowing the support of others

  • Feeling comfortable with the course of action you choose

Many survivors find it helpful to join an in-person support group or an online community of survivors. This allows you to talk with people who have had similar first-hand experiences. Other options for finding support include talking with a friend or member of your health care team, individual counseling, or asking for assistance at the learning resource center of the place where you received treatment.

A new perspective on your health

For many people, survivorship serves as a strong motivator to make lifestyle changes.

People recovering from inflammatory breast cancer are encouraged to follow established guidelines for good health, such as not smoking, limiting alcohol, eating well, exercising regularly, and managing stress. Regular physical activity can help rebuild your strength and energy level. Maintaining a healthy weight may also help lower the risk of a breast cancer recurrence and other medical conditions such as diabetes and heart disease. Your health care team can help you create an appropriate exercise plan based on your needs, physical abilities, and fitness level. Learn more about making healthy lifestyle choices.

To take care of your health, it is important to have recommended medical checkups and tests (see Follow-Up Care and Monitoring) and to follow up with your primary health care provider.

Talk with your health care team to develop a survivorship care plan that is best for your needs.

Changing role of caregivers

Family members and friends may also go through periods of transition. A caregiver plays a very important role in supporting a person diagnosed with cancer, providing physical, emotional, and practical care on a daily or as-needed basis. Many caregivers become focused on providing this support, especially if the treatment period lasts for many months or longer.

However, as treatment is completed, the caregiver's role often changes. Eventually, the need for caregiving related to the cancer diagnosis will become much less or come to an end. Caregivers can learn more about adjusting to life after caregiving.

Looking for More Survivorship Resources?

For more information about cancer survivorship, explore these related items. Please note that these links will take you to other sections of Cancer.Net:

  • ASCO Answers Guide to Cancer Survivorship: Get this 48-page booklet that helps people transition into life after treatment. It includes blank treatment summary and survivorship care plan forms. The free booklet is available as a PDF, so it is easy to print.

  • Survivorship Resources: Cancer.Net offers information and resources to help survivors cope, including specific sections for children, teens and young adults, and people over age 65. There is also a main section on survivorship for people of all ages.

The next section offers Questions to Ask the Health Care Team to help start conversations with your cancer care team. Use the menu to choose a different section to read in this guide.

Breast Cancer - Inflammatory - Questions to Ask the Health Care Team

Approved by the Cancer.Net Editorial Board, 06/2022

ON THIS PAGE: You will find some questions to ask the health care team to help you better understand your diagnosis, treatment plan, and overall care. Use the menu to see other pages.

Cancer.Net Mobile app question tracker

Talking often with the health care team is important to make informed decisions about your health care. These suggested questions are a starting point to help you learn more about your cancer care and treatment. You are also encouraged to ask additional questions that are important to you. You may want to print this list and bring it to your next appointment, or download Cancer.Net’s free mobile app for a digital list and other interactive tools to manage your care. It may also be helpful to ask a family member or friend to come with you to appointments to help take notes.

Questions to ask after getting a diagnosis

  • What type of breast cancer do I have?

  • What stage is the cancer? What does this mean?

  • Can you explain my pathology report (laboratory test results) to me?

Questions to ask about choosing treatment and managing side effects

  • What are my treatment options?

  • What clinical trials are available for me? Where are they located, and how do I find out more about them?

  • What treatment plan do you recommend? Why?

  • What are the chances that the cancer will be successfully treated?

  • Who will be part of my health care team, and what does each member do?

  • Who will be leading my overall treatment?

  • What is the goal of each treatment? Is it to eliminate the cancer, help me feel better, or both?

  • What are the possible side effects of this treatment, both in the short term and the long term?

  • How will this treatment affect my daily life? Will I be able to work, exercise, and perform my usual activities?

  • Could this treatment affect my sex life? If so, how and for how long?

  • Could this treatment affect my ability to become pregnant or have children? If so, should I talk with a fertility specialist before cancer treatment begins?

  • If I’m worried about managing the costs of cancer care, who can help me?

  • How can I keep myself as healthy as possible during treatment?

  • How can I learn more about this specific type of breast cancer?

  • What support services are available to me? To my family?

  • If I have questions or problems, who should I call?

Questions to ask about chemotherapy, hormone therapy, or targeted therapy

  • What is the goal of this treatment?

  • How long will it take to give this treatment?

  • Will I receive this treatment at a hospital or clinic? Or will I take it at home?

  • What side effects can I expect during treatment?

  • Who should I contact about any side effects I experience? And how soon?

  • What are the possible long-term or late effects of having this treatment?

  • What can be done to prevent or relieve the side effects?

Questions to ask about having surgery

  • What type of surgery will I have? Will lymph nodes be removed?

  • How long will the operation take?

  • How long will I be in the hospital?

  • Can you describe what my recovery from surgery will be like?

  • Who should I contact about any side effects I experience? And how soon?

  • What are the possible long-term effects of having this surgery?

Questions to ask about breast reconstruction

  • Is breast reconstruction an option for me?

  • What types of breast reconstruction options do I have?

  • What are the advantages and disadvantages of each type?

Questions to ask about planning follow-up care

  • What is the chance that the cancer will come back? Should I watch for specific signs or symptoms?

  • What long-term side effects or late effects are possible based on the cancer treatment I received?

  • What follow-up tests will I need, and how often will those tests be needed?

  • How do I get a treatment summary and survivorship care plan to keep in my personal records?

  • Who will be leading my follow-up care?

  • What survivorship support services are available to me? To my family?

For additional questions, see the Guide to Breast Cancer.

The next section in this guide is Additional Resources. It offers more resources on this website that may be helpful to you. Use the menu to choose a different section to read in this guide.

Breast Cancer - Inflammatory - Additional Resources

Approved by the Cancer.Net Editorial Board, 06/2022

ON THIS PAGE: You will find some helpful links to other areas of Cancer.Net that provide information about cancer care and treatment. This is the final page of Cancer.Net’s Guide to Inflammatory Breast Cancer. Use the menu to go back and see other pages.

Cancer.Net includes many other sections about the medical and emotional aspects of cancer for the person diagnosed and their family members and friends. This website is meant to be a resource for you and your loved ones from the time of diagnosis, through treatment, and beyond.

Here are a few links to help you explore other parts of Cancer.Net:

This is the end of Cancer.Net’s Guide to Inflammatory Breast Cancer. Use the menu to choose a different section to read in this guide.